Core Scientific annual stock-based compensation
2020
2021
2022
2023
2024
2025
Core Scientific Stock-Based Compensation Growth & History (CORZ)
Core Scientific's stock-based compensation was $98.2M for fiscal 2025.
View full Core Scientific company overviewCore Scientific annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $98.2M | $46.3M | +89.19% |
| 2024 | 2024-12-31 | $51.9M | −$7.0M | −11.83% |
| 2023 | 2023-12-31 | $58.9M | −$124.0M | −67.80% |
| 2022 | 2022-12-31 | $182.9M | $144.0M | +369.72% |
| 2021 | 2021-12-31 | $38.9M | $35.9M | +1182.09% |
| 2020 | 2020-12-31 | $3.0M | — | — |
Core Scientific quarterly stock-based compensation
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $18.2M | −$5.9M | −24.53% |
| Q1 2026 | 2026-03-31 | $17.8M | $1.6M | +9.74% |
| Q4 2025 | 2025-12-31 | $27.9M | $4.0M | +16.56% |
| Q3 2025 | 2025-09-30 | $29.9M | $9.4M | +45.91% |
| Q2 2025 | 2025-06-30 | $24.2M | $15.7M | +184.55% |
| Q1 2025 | 2025-03-31 | $16.2M | $17.2M | — |
| Q4 2024 | 2024-12-31 | $24.0M | $6.5M | +37.13% |
| Q3 2024 | 2024-09-30 | $20.5M | $5.7M | +38.10% |
| Q2 2024 | 2024-06-30 | $8.5M | −$5.8M | −40.52% |
| Q1 2024 | 2024-03-31 | −$1.1M | −$13.3M | — |
| Q4 2023 | 2023-12-31 | $17.5M | $1.1M | +6.93% |
| Q3 2023 | 2023-09-30 | $14.9M | −$14.9M | −50.05% |
| Q2 2023 | 2023-06-30 | $14.3M | −$96.7M | −87.13% |
| Q1 2023 | 2023-03-31 | $12.3M | −$13.5M | −52.42% |
| Q4 2022 | 2022-12-31 | $16.3M | $8.4M | +106.26% |
| Q3 2022 | 2022-09-30 | $29.8M | $1.5M | +5.18% |
| Q2 2022 | 2022-06-30 | $111.0M | $108.9M | +5096.54% |
| Q1 2022 | 2022-03-31 | $25.8M | $25.2M | +4287.24% |
| Q4 2021 | 2021-12-31 | $7.9M | — | — |
| Q3 2021 | 2021-09-30 | $28.3M | — | — |
| Q2 2021 | 2021-06-30 | $2.1M | — | — |
| Q1 2021 | 2021-03-31 | $588,000 | — | — |
Core Scientific stock-based compensation trends
Over the last five fiscal years, Core Scientific's stock-based compensation increased from $3.0M to $98.2M, a change of $95.2M. The latest reported quarter, Q2 2026, shows $18.2M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Core Scientific source filings ↗